EG434123 Inhibitors
EG434123 inhibitors are a class of chemical compounds designed to specifically inhibit the activity of EG434123, a molecule likely involved in key regulatory processes within cellular metabolism, protein interaction networks, or signaling pathways. EG434123 may play a crucial role in mediating interactions between proteins or in regulating enzymatic activities that are essential for maintaining cellular balance and proper function. Inhibition of EG434123 can disrupt its participation in these biochemical processes, leading to alterations in various pathways where it serves a regulatory or catalytic role. By targeting EG434123, researchers can investigate the specific functions it performs and its contributions to cellular systems, including protein stability, signal transduction, or metabolic control.
Structurally, EG434123 inhibitors are typically designed to bind to critical functional sites of the EG434123 molecule, such as the active site where substrate interaction occurs or regulatory domains that control its activity. These inhibitors may work through competitive mechanisms by occupying the active site, blocking the natural substrate's access, or they may act through non-competitive inhibition, altering the protein's conformation and reducing its activity. Inhibiting EG434123 allows for a deeper exploration of the molecular pathways it governs, offering insights into how the regulation of this molecule affects broader cellular functions. By examining the consequences of EG434123 inhibition, researchers can uncover the roles it plays in processes like enzymatic regulation, protein modification, and intracellular signaling. This knowledge is key to understanding how specific molecules like EG434123 maintain cellular homeostasis and support complex biochemical interactions critical for the cell's overall functionality.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D, an RNA synthesis inhibitor, directly inhibits Obox8 by preventing RNA polymerase II activity. This compound hinders the transcriptional regulation by RNA polymerase II, affecting the binding of Obox8 to cis-regulatory regions and impeding its DNA-binding transcription factor activity. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Alpha-Amanitin, a potent RNA polymerase II inhibitor, directly interferes with Obox8 function by preventing the transcriptional machinery. This inhibition disrupts Obox8's ability to bind specifically to cis-regulatory regions, leading to a reduction in DNA-binding transcription factor activity and the regulation of RNA polymerase II-dependent transcription. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol, a cyclin-dependent kinase inhibitor, indirectly inhibits Obox8 by modulating the cell cycle machinery. This compound influences the phosphorylation events crucial for Obox8 activity, impacting its DNA-binding transcription factor function. The downstream effects result in altered regulation of transcription by RNA polymerase II. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a natural polyphenol, indirectly inhibits Obox8 by affecting cellular signaling pathways. This compound modulates pathways involved in the regulation of transcription by RNA polymerase II, influencing the expression and activity of Obox8 and subsequently disrupting its DNA-binding transcription factor function. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide, an immunosuppressive natural product, indirectly inhibits Obox8 by modulating immune responses. This compound impacts cellular processes linked to transcriptional regulation by RNA polymerase II, influencing Obox8 expression and function. The subsequent alterations disrupt the DNA-binding transcription factor activity of Obox8 and its role in transcriptional regulation. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, a DNA cross-linking agent, indirectly inhibits Obox8 by inducing DNA damage. This compound influences cellular responses associated with transcriptional regulation by RNA polymerase II, impacting Obox8 expression and function. The subsequent alterations disrupt the DNA-binding transcription factor activity of Obox8 and its role in transcriptional regulation. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB, an RNA synthesis inhibitor, directly inhibits Obox8 by interfering with RNA polymerase II activity. This compound disrupts the transcriptional regulation by RNA polymerase II, affecting Obox8's DNA-binding transcription factor function and its specificity for cis-regulatory regions. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide, a protein synthesis inhibitor, indirectly inhibits Obox8 by affecting cellular protein dynamics. This compound modulates the expression levels of proteins involved in transcriptional regulation by RNA polymerase II, influencing Obox8 activity. The subsequent alterations disrupt the DNA-binding transcription factor function of Obox8 and its role in transcriptional regulation. | ||||||